After reviewing the earnings released by Medtronic and listening to the call the vision that came to us was a patient laying on the operating table suffering from multiple self-inflicted gunshot wounds who was bleeding from every orifice. Unfortunately for the patient a skilled surgeon was not standing at table but Bevis and Butthead.
How bad is it?
Domestic sales declined
The company is guiding toward the lower range of growth 6 to 8%
And as the company acknowledged the competitive environment is getting even tougher
Before we go on here . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.